For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Sugammadex (Selective relaxant binding agent (rocuronium/vecuronium)) – indications: Routine reversal – recovery to T2 (TOF), Deep block – 1–2 post-tetanic counts, Immediate reversal after rocuronium 1.2 mg/kg – adults. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Routine reversal – recovery to T2 (TOF)
- Deep block – 1–2 post-tetanic counts
- Immediate reversal after rocuronium 1.2 mg/kg – adults
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Used in
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.